Patents by Inventor Pierre-Yves Desprez

Pierre-Yves Desprez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RESORCINOL-BASED COMPOUNDS AND USES THEREOF
    Publication number: 20240059646
    Abstract: The disclosure provides for resorcinol-based compounds, pharmaceutical compositions made therefrom, and methods of treatment thereof for various disorders, including neoplastic disorders.
    Type: Application
    Filed: December 16, 2021
    Publication date: February 22, 2024
    Inventors: Sean D. McAllister, Pierre-Yves Desprez, Anuradha Mahadevan, Ravi K. Ujjinamatada
  • Methods and compositions for treating cancer
    Patent number: 11344527
    Abstract: This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.
    Type: Grant
    Filed: November 8, 2013
    Date of Patent: May 31, 2022
    Assignee: Sutter Bay Hospitals
    Inventors: Sean D. McAllister, Pierre-Yves Desprez
  • Methods and compositions for treating cancer
    Patent number: 11260043
    Abstract: This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.
    Type: Grant
    Filed: December 31, 2014
    Date of Patent: March 1, 2022
    Assignee: SUTTER BAY HOSPITALS
    Inventors: Sean D. McAllister, Pierre-Yves Desprez
  • Resorcinol derivatives
    Patent number: 10202322
    Abstract: The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.
    Type: Grant
    Filed: November 1, 2017
    Date of Patent: February 12, 2019
    Assignee: Sutter Bay Hospitals
    Inventors: Sean D. McAllister, Pierre-Yves Desprez, Anuradha Mahadevan
  • RESORCINOL DERIVATIVES
    Publication number: 20180170846
    Abstract: The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.
    Type: Application
    Filed: November 1, 2017
    Publication date: June 21, 2018
    Inventors: Sean D. McAllister, Pierre-Yves Desprez, Anuradha Mahadevan
  • Cannabidinoid derivatives
    Patent number: 9809521
    Abstract: The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.
    Type: Grant
    Filed: January 25, 2016
    Date of Patent: November 7, 2017
    Assignee: SUTTER WEST BAY HOSPITALS
    Inventors: Sean D. McAllister, Pierre-Yves Desprez, Anuradha Mahadevan
  • CANNABIDINOID DERIVATIVES
    Publication number: 20160376211
    Abstract: The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.
    Type: Application
    Filed: January 25, 2016
    Publication date: December 29, 2016
    Inventors: Sean D. McAllister, Pierre-Yves Desprez, Anuradha Mahadevan
  • Resorcinol derivatives
    Patent number: 9254272
    Abstract: The disclosure relates to cannabinoid derivative compounds, pharmaceutical compositions made thereof, and methods for treating various diseases and disorders including cancer.
    Type: Grant
    Filed: November 30, 2012
    Date of Patent: February 9, 2016
    Assignee: Sutter West Bay Hospitals
    Inventors: Sean D. McAllister, Pierre-Yves Desprez, Anuradha Mahadevan
  • METHODS AND COMPOSITIONS FOR TREATING CANCER
    Publication number: 20150320720
    Abstract: This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.
    Type: Application
    Filed: July 17, 2015
    Publication date: November 12, 2015
    Applicant: Sutter West Bay Hospitals
    Inventors: Sean D. McAllister, Pierre-Yves Desprez
  • Methods and compositions for treating cancer
    Patent number: 9084771
    Abstract: This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.
    Type: Grant
    Filed: May 16, 2008
    Date of Patent: July 21, 2015
    Assignee: Sutter West Bay Hospitals
    Inventors: Sean D. McAllister, Pierre-Yves Desprez
  • METHODS AND COMPOSITIONS FOR TREATING CANCER
    Publication number: 20150150844
    Abstract: This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.
    Type: Application
    Filed: December 31, 2014
    Publication date: June 4, 2015
    Inventors: Sean D. McAllister, Pierre-Yves Desprez
  • and genes and products as therapeutic targets for treatment of breast cancer and other types of carcinoma
    Patent number: 8846629
    Abstract: A method for treatment and amelioration of breast, cervical, ovarian, endometrial, squamous cells, prostate cancer and melanoma in a patient comprising targeting Id-1 or Id-2 gene expression with a delivery vehicle comprising a product which modulates Id-1 or Id-2 expression.
    Type: Grant
    Filed: December 2, 2008
    Date of Patent: September 30, 2014
    Assignees: The Regents of the University of California, California Pacific Medical Center Research Institute
    Inventors: Pierre-Yves Desprez, Judith Campisi
  • gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma
    Patent number: 8809291
    Abstract: A method for treatment of breast cancer and other types of cancer. The method comprises targeting and modulating Id-1 gene expression, if any, for the Id-1 gene, or gene products in breast or other epithelial cancers in a patient by delivering products that modulate Id-1 gene expression. When expressed, Id-1 gene is a prognostic indicator that cancer cells are invasive and metastatic.
    Type: Grant
    Filed: October 3, 2011
    Date of Patent: August 19, 2014
    Assignees: California Pacific Medical Center Research Institute, The Regents of the University of California
    Inventors: Pierre-Yves Desprez, Judith Campisi
  • METHODS AND COMPOSITIONS FOR TREATING CANCER
    Publication number: 20140065243
    Abstract: This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.
    Type: Application
    Filed: November 8, 2013
    Publication date: March 6, 2014
    Inventors: Sean D. McAllister, Pierre-Yves Desprez
  • Id-1 Gene and Gene Products as Therapeutic Targets for Treatment of Breast Cancer and Other Types of Carcinoma
    Publication number: 20120021047
    Abstract: A method for treatment of breast cancer and other types of cancer. The method comprises targeting and modulating Id-1 gene expression, if any, for the Id-1 gene, or gene products in breast or other epithelial cancers in a patient by delivering products that modulate Id-1 gene expression. When expressed, Id-1 gene is a prognostic indicator that cancer cells are invasive and metastatic.
    Type: Application
    Filed: October 3, 2011
    Publication date: January 26, 2012
    Applicants: California Pacific Medical Center Research Institute, THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Pierre-Yves Desprez, Judith Campisi
  • Id-1 and Id-2 genes and products as markers of epithelial cancer
    Patent number: 8030012
    Abstract: A method for detection and prognosis of breast cancer and other types of cancer. The method comprises detecting expression, if any, for both an Id-1 and an Id-2 genes, or the ratio thereof, of gene products in samples of breast tissue obtained from a patient. When expressed, Id-1 gene is a prognostic indicator that breast cancer cells are invasive and metastatic, whereas Id-2 gene is a prognostic indicator that breast cancer cells are localized and noninvasive in the breast tissue.
    Type: Grant
    Filed: March 27, 2006
    Date of Patent: October 4, 2011
    Assignee: The Regents of the University of California
    Inventors: Pierre-Yves Desprez, Judith Campisi
  • METHODS AND COMPOSITIONS FOR TREATING CANCER
    Publication number: 20100204312
    Abstract: This disclosure provides compositions and method useful for treating cell proliferative disorders including cancer. The disclosure provides cannabidiol derivatives and compositions thereof either alone or in combination with THC or a derivative thereof.
    Type: Application
    Filed: May 16, 2008
    Publication date: August 12, 2010
    Applicant: CALIFORNIA PACIFIC MEDICAL CENTER
    Inventors: Sean D. McAllister, Pierre-Yves Desprez
  • Id-1 and Id-2 Genes and Products as Therapeutic Targets for Treatment of Breast Cancer and Other Types of Carcinoma
    Publication number: 20090180988
    Abstract: A method for treatment and amelioration of breast, cervical, ovarian, endometrial, squamous cells, prostate cancer and melanoma in a patient comprising targeting Id-1 or Id-2 gene expression with a delivery vehicle comprising a product which modulates Id-1 or Id-2 expression.
    Type: Application
    Filed: December 2, 2008
    Publication date: July 16, 2009
    Applicants: The Regents of the University of California, California Pacific Medical Center Research Institute
    Inventors: Pierre-Yves Desprez, Judith Campisi
  • Id-1 and Id-2 genes and products as markers of epithelial cancer
    Patent number: 7429457
    Abstract: A method for detection and prognosis of breast cancer and other types of cancer. The method comprises detecting expression, if any, for both an Id-1 and an Id-2 genes, or the ratio thereof, of gene products in samples of breast tissue obtained from a patient. When expressed, Id-1 gene is a prognostic indicator that breast cancer cells are invasive and metastatic, whereas Id-2 gene is a prognostic indicator that breast cancer cells are localized and noninvasive in the breast tissue.
    Type: Grant
    Filed: September 14, 2001
    Date of Patent: September 30, 2008
    Assignees: The Regents of the University of California, California Pacific Medical Center
    Inventors: Pierre-Yves Desprez, Judith Campisi
  • Id-1 and Id-2 genes and products as markers of epithelial cancer
    Publication number: 20060234273
    Abstract: A method for detection and prognosis of breast cancer and other types of cancer. The method comprises detecting expression, if any, for both an Id-1 and an Id-2 genes, or the ratio thereof, of gene products in samples of breast tissue obtained from a patient. When expressed, Id-1 gene is a prognostic indicator that breast cancer cells are invasive and metastatic, whereas Id-2 gene is a prognostic indicator that breast cancer cells are localized and noninvasive in the breast tissue.
    Type: Application
    Filed: March 27, 2006
    Publication date: October 19, 2006
    Applicants: The Regents of the University of California
    Inventors: Pierre-Yves Desprez, Judith Campisi